June 16 Media Roundup
Can adaptive trials change the way we treat Alzheimer’s disease?
From 3-D printing to artificial hearts, take a look inside labs growing human tissue.
The National Academies of Sciences, Engineering and Medicine now endorses revolutionary “gene drive” technology research to alter disease-carrying species.
Can artificial intelligence outsmart tumors? New research presented at ASCO 2016.
This rare disease could be a gateway to treating Alzheimer’s and other common neurodegenerative diseases.
Acute myeloid leukemia breakthrough: Research uncovering 11 categories of the disease may aid diagnosis/treatment.
Looking back at ASCO 2016 and promising immunotherapy breakthroughs.A “totally different species?”
From superpowers to designer babies, genetic engineering could change mankind.
An experimental therapy for multiple sclerosis could regenerate patients’ immune systems.
MD Anderson Cancer Center Jim Allison has a dream to make a melanoma immunotherapy a reality.
Can digital quantum computing crack the toughest problems in healthcare?
Cognitive computing comes to diabetes research with the help of the American Diabetes Association and IBM Watson Health.
Donation goes digital: NHS Blood and Transplant (NHSBT) will notify donors via text when their blood is sent to a hospital.
Health IT was the hot topic at the American Medical Association’s annual meeting.
Researchers have incorporated the gene-editing software CRISPR into a new test to differentiate between two strains of the Zika virus. While most gene-editing research has been focused on developing treatments, some scientists are beginning to shift their attention to the diagnostic potential of CRISPR. There’s even talk of developing a paper strip test to classify bacterial infections in the developing world.
We’re about to get a whole lot smarter if genomics can impact human cognitive ability.
High-techbionic limbs challenge the way we think about prosthetics.
The White House goes all in on organ transplants. At Monday’s Organ Summit, the Obama administration announced a new effort to improve approaches to organ transplants, including a $160 million investment focused on rallying industry, academia and nonprofits to discover new ways to replace organs. The newly created Advanced Tissue Biofabrication Manufacturing Innovation Institute will explore technology with the aim of repairing, and eventually replacing, human cells and tissues.